Accessibility Menu
Caliber Imaging & Diagnostics logo

Caliber Imaging & Diagnostics

(OTC) LCDX

Current Price$0.00
Market Cap$5,100
Since IPO (2012)-100%
5 Year-100%
1 Year+500%
1 Month+0%

Caliber Imaging & Diagnostics Financials at a Glance

Market Cap

$5,100

Revenue (TTM)

$3.14M

Net Income (TTM)

$6.25M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-52.83 (Low)

Price

$0.00

Volume

460

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

LCDX News

No articles available.

LCDX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Caliber Imaging & Diagnostics

Industry

Healthcare Equipment and Supplies

Headquarters

Andover, MA 01810, US

LCDX Financials

Key Financial Metrics (TTM)

Gross Margin

20%

Operating Margin

-1%

Net Income Margin

-2%

Return on Equity

0%

Return on Capital

97%

Return on Assets

-2%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$5.10K

Shares Outstanding

8.51M

Volume

460

Short Interest

0.00%

Avg. Volume

1.03K

Financials (TTM)

Gross Profit

$653.86K

Operating Income

$4.85M

EBITDA

$4.68M

Operating Cash Flow

$4.84M

Capital Expenditure

$27.65K

Free Cash Flow

$4.86M

Cash & ST Invst.

$786.51K

Total Debt

$11.78M

Caliber Imaging & Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q1 2014YOY CHG

Revenue

$858.14K

-18.9%

Gross Profit

$142.36K

-54.1%

Gross Margin

16.59%

N/A

Market Cap

$5.10K

N/A

Market Cap/Employee

$182.14

N/A

Employees

28

N/A

Net Income

$1.82M

-73.2%

EBITDA

$1.59M

-75.1%

Quarterly Fundamentals

Name
Q1 2014YOY CHG

Net Cash

$4.89M

-14648.4%

Accounts Receivable

$390.86K

+16.5%

Inventory

$1.01M

+33.5%

Long Term Debt

$0.00

N/A

Short Term Debt

$5.12M

+1297.7%

Return on Assets

-2.28%

N/A

Return on Invested Capital

96.99%

N/A

Free Cash Flow

$656.97K

-13.2%

Operating Cash Flow

$485.21K

+14.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NMRDNemaura Medical Inc.
$0.00+0.00%
BBALNew York Health Care, Inc.
$0.00+0.00%
FPMIFluoroPharma Medical, Inc.
$0.00+0.00%
NWCINewCardio, Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.58+0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.54-0.03%
TLTiShares Trust - iShares 20+ Year Treasury Bond ETF
$86.05-0.02%
PLPlanet Labs PBC
$33.91+0.26%

Questions About LCDX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.